Abstract | BACKGROUND: METHODS: Patients with MSSA bacteremia recruited from a tertiary referral hospital were enrolled in this retrospective cohort study. Demographic characteristics, laboratory data, and clinical outcome of the treatment were compared between a group receiving nafcillin and a group receiving glycopeptides. RESULTS: CONCLUSION:
|
Authors | Dong Hyun Oh, Jung Ju Kim, Jinnam Kim, Hye Seong, Se Ju Lee, Yong Chan Kim, Eun Jin Kim, In Young Jung, Woo Yong Jeong, Su Jin Jeong, Nam Su Ku, Sang Hoon Han, Jun Yong Choi, Young Goo Song, June Myung Kim |
Journal | BMC infectious diseases
(BMC Infect Dis)
Vol. 18
Issue 1
Pg. 60
(01 30 2018)
ISSN: 1471-2334 [Electronic] England |
PMID | 29378565
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Glycopeptides
- Nafcillin
- C-Reactive Protein
- Methicillin
|
Topics |
- Adult
- Aged
- Anti-Bacterial Agents
(pharmacology, therapeutic use)
- Bacteremia
(drug therapy)
- C-Reactive Protein
(analysis)
- Cohort Studies
- Cross Infection
(complications)
- Female
- Glycopeptides
(therapeutic use)
- Hospital Mortality
- Humans
- Intensive Care Units
- Male
- Methicillin
(pharmacology)
- Middle Aged
- Nafcillin
(therapeutic use)
- Proportional Hazards Models
- Retrospective Studies
- Staphylococcal Infections
(complications, drug therapy, microbiology, mortality)
- Staphylococcus aureus
(drug effects, isolation & purification)
- Tertiary Care Centers
|